Cytokine modified tumor vaccines

Research output: Contribution to journalReview articlepeer-review

Abstract

The immune system can recognize tumors, but may be actively tolerized to tumors during the tumorigenesis process. The identity of most tumor antigens remains unknown, but the number is growing due to new techniques. Most clinical trials using genetically modified tumor vaccines have shown immunological responses (DTH), but few clinical responses. Certain chemotherapeutic agents may enhance the immune effects of genetically modified tumor vaccines.

Original languageEnglish (US)
Pages (from-to)681-696
Number of pages16
JournalSurgical Oncology Clinics of North America
Volume11
Issue number3
DOIs
StatePublished - Jul 2002

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Cytokine modified tumor vaccines'. Together they form a unique fingerprint.

Cite this